Tandem Diabetes Agrees to Pay Roche $36 Million in Patent Infringement Deal

 Tandem Diabetes Care has agreed to pay Roche Holding $36 million to settle a patent infringement claim.

The two companies have granted each other licenses to patents on the insulin delivery systems in question for the next 10 years, Tandem said Friday.

Swiss pharmaceutical company Roche filed an action in December 2023 alleging one of Tandem's insulin pumps infringed upon its patent. Roche was seeking monetary damages and for Tandem to stop selling the t:slim X2 pump.

San Diego-based Tandem will make an initial payment of $8 million under the agreement, and pay out the remaining balance in equal installments over the next four years.

https://www.morningstar.com/news/dow-jones/202505239271/tandem-diabetes-agrees-to-pay-roche-36-million-in-patent-infringement-deal